BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

INEX Pharmaceuticals (IEX.TO) Conference Call Advisory - 2006 Year End Operating Results


3/20/2007 3:54:32 PM

VANCOUVER, March 20 /PRNewswire-FirstCall/ - Inex Pharmaceuticals Corporation announced today that it will hold a conference call and webcast on Wednesday March 21, 2007 at 9:00 am PST (12:00 noon EST) to discuss 2006 year end operating results and to provide an update on developments at the Company.

About the Conference Call

To participate in the conference call, please dial 416-641-6115 or 1-866-542-4241. The call will be available for replay until March 28, 2007 by calling 416-695-5800 or 1-800-408-3053 and entering the pass code 3217983.

The live or archived webcast can also be accessed through the Company's website at www.inexpharm.com.

About INEX

INEX is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. Further information about INEX and this news release can be found at www.inexpharm.com.

INEX's common shares are traded on the Toronto Stock Exchange under the trading symbol "IEX".

CONTACT: Contacts for Inex Pharmaceuticals Corporation: Investors: Ian Mortimer, Vice President, Finance and Chief Financial Officer, Phone: (604) 419-3200; Media: Karen Cook Boas, James Hoggan & Associates Inc., Phone: (604) 739-7500, Email: kcook@hoggan.com

Inex Pharmaceuticals Corporation

CONTACT: Contacts for Inex Pharmaceuticals Corporation: Investors: IanMortimer, Vice President, Finance and Chief Financial Officer, Phone: (604)419-3200; Media: Karen Cook Boas, James Hoggan & Associates Inc., Phone:(604) 739-7500, Email: kcook@hoggan.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES